Literature DB >> 25035521

Group testing in heterogeneous populations by using halving algorithms.

Michael S Black1, Christopher R Bilder1, Joshua M Tebbs2.   

Abstract

Group (pooled) testing is often used to reduce the total number of tests that are needed to screen a large number of individuals for an infectious disease or some other binary characteristic. Traditionally, research in group testing has assumed that each individual is independent with the same risk of positivity. More recently, there has been a growing set of literature generalizing previous work in group testing to include heterogeneous populations so that each individual has a different risk of positivity. We investigate the effect of acknowledging population heterogeneity on a commonly used group testing procedure which is known as 'halving'. For this procedure, positive groups are successively split into two equal-sized halves until all groups test negatively or until individual testing occurs. We show that heterogeneity does not affect the mean number of tests when individuals are randomly assigned to subgroups. However, when individuals are assigned to subgroups on the basis of their risk probabilities, we show that our proposed procedures reduce the number of tests by taking advantage of the heterogeneity. This is illustrated by using chlamydia and gonorrhoea screening data from the state of Nebraska.

Entities:  

Keywords:  Binary response; Classification; Identification; Pooled testing; Retesting; Screening

Year:  2012        PMID: 25035521      PMCID: PMC4097341          DOI: 10.1111/j.1467-9876.2011.01008.x

Source DB:  PubMed          Journal:  J R Stat Soc Ser C Appl Stat        ISSN: 0035-9254            Impact factor:   1.864


  11 in total

1.  Regression models for disease prevalence with diagnostic tests on pools of serum samples.

Authors:  S Vansteelandt; E Goetghebeur; T Verstraeten
Journal:  Biometrics       Date:  2000-12       Impact factor: 2.571

2.  Group testing in presence of classification errors.

Authors:  D Gupta; R Malina
Journal:  Stat Med       Date:  1999-05-15       Impact factor: 2.373

3.  Comparison of group testing algorithms for case identification in the presence of test error.

Authors:  Hae-Young Kim; Michael G Hudgens; Jonathan M Dreyfuss; Daniel J Westreich; Christopher D Pilcher
Journal:  Biometrics       Date:  2007-05-14       Impact factor: 2.571

4.  Reverse transcription-polymerase chain reaction on pooled samples to detect bovine viral diarrhea virus by using fresh ear-notch-sample supernatants.

Authors:  James A Kennedy; Robert G Mortimer; Barbara Powers
Journal:  J Vet Diagn Invest       Date:  2006-01       Impact factor: 1.279

5.  Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.

Authors:  R Y Dodd; E P Notari; S L Stramer
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

6.  Informative Retesting.

Authors:  Christopher R Bilder; Joshua M Tebbs; Peng Chen
Journal:  J Am Stat Assoc       Date:  2010-09-01       Impact factor: 5.033

7.  Detection of acute infections during HIV testing in North Carolina.

Authors:  Christopher D Pilcher; Susan A Fiscus; Trang Q Nguyen; Evelyn Foust; Leslie Wolf; Del Williams; Rhonda Ashby; Judy Owen O'Dowd; J Todd McPherson; Brandt Stalzer; Lisa Hightow; William C Miller; Joseph J Eron; Myron S Cohen; Peter A Leone
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

8.  Three-dimensional array-based group testing algorithms.

Authors:  Hae-Young Kim; Michael G Hudgens
Journal:  Biometrics       Date:  2008-11-13       Impact factor: 2.571

9.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Authors:  Susan L Stramer; Simone A Glynn; Steven H Kleinman; D Michael Strong; Sally Caglioti; David J Wright; Roger Y Dodd; Michael P Busch
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 10.  Introduction of Chlamydia trachomatis screening for young women in Germany.

Authors:  Monika Mund; Gabriele Sander; Peter Potthoff; Helga Schicht; Katja Matthias
Journal:  J Dtsch Dermatol Ges       Date:  2008-05-07       Impact factor: 5.584

View more
  9 in total

1.  Bayesian regression for group testing data.

Authors:  Christopher S McMahan; Joshua M Tebbs; Timothy E Hanson; Christopher R Bilder
Journal:  Biometrics       Date:  2017-04-12       Impact factor: 2.571

2.  Group testing case identification with biomarker information.

Authors:  Dewei Wang; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Comput Stat Data Anal       Date:  2018-02-01       Impact factor: 1.681

3.  Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations.

Authors:  Christopher R Bilder; Joshua M Tebbs
Journal:  Stat Med       Date:  2012-03-13       Impact factor: 2.373

4.  The objective function controversy for group testing: Much ado about nothing?

Authors:  Brianna D Hitt; Christopher R Bilder; Joshua M Tebbs; Christopher S McMahan
Journal:  Stat Med       Date:  2019-08-30       Impact factor: 2.373

5.  Optimal retesting configurations for hierarchical group testing.

Authors:  Michael S Black; Christopher R Bilder; Joshua M Tebbs
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2015-08-01       Impact factor: 1.864

6.  Nested Group Testing Procedure.

Authors:  Wenjun Xiong; Juan Ding; Wei Zhang; Aiyi Liu; Qizhai Li
Journal:  Commun Math Stat       Date:  2022-10-01

7.  Hierarchical group testing for multiple infections.

Authors:  Peijie Hou; Joshua M Tebbs; Christopher R Bilder; Christopher S McMahan
Journal:  Biometrics       Date:  2016-09-22       Impact factor: 2.571

8.  Group testing regression model estimation when case identification is a goal.

Authors:  Boan Zhang; Christopher R Bilder; Joshua M Tebbs
Journal:  Biom J       Date:  2013-02-08       Impact factor: 2.207

9.  Pooled testing of traced contacts under superspreading dynamics.

Authors:  Stratis Tsirtsis; Abir De; Lars Lorch; Manuel Gomez-Rodriguez
Journal:  PLoS Comput Biol       Date:  2022-03-28       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.